These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25177003)

  • 1. [Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Sep; 24(9):1309-18. PubMed ID: 25177003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucocorticoid-induced osteoporosis].
    Suzuki Y
    Nihon Rinsho; 2015 Oct; 73(10):1733-9. PubMed ID: 26529939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Drug-induced osteoporosis: glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2015 Sep; 25(9):1347-56. PubMed ID: 26320535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T
    Clin Calcium; 2015 Dec; 25(12):1825-34. PubMed ID: 26608858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoid and Bone. The changes of Japanese and foreign guidelines for the management of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2014 Sep; 24(9):1301-8. PubMed ID: 25177002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis].
    Yamamoto M; Sugimoto T
    Clin Calcium; 2014 Sep; 24(9):1379-85. PubMed ID: 25177011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucocorticoid and bone].
    Soen S
    Clin Calcium; 2014 Jun; 24(6):829-36. PubMed ID: 24870833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucocorticoid-induced osteoporosis : treatment update].
    Soen S
    Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
    Nakayama H
    Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis].
    Miki T; Okamoto K
    Clin Calcium; 2014 Sep; 24(9):1387-92. PubMed ID: 25177012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
    Soen S
    Nihon Rinsho; 2009 May; 67(5):985-90. PubMed ID: 19432121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Moriwaki K; Fukuda H
    Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.